Revenue
2022
2023
2024
2025
Exosens (EXENS)
Price€55.20Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | €468.2M | €383.4M | €291.8M | €200.8M |
| Operating expenses | €141.7M | €175.3M | €156.9M | €81.0M |
| Operating income | €102.0M | €76.8M | €48.3M | €33.0M |
| Operating margin | 21.79% | 20.02% | 16.55% | 16.41% |
| EBITDA | €120.1M | €142.1M | €75.3M | €51.2M |
| EBITDA margin | 25.65% | 37.06% | 25.79% | 25.53% |
| Net income | €42.7M | €30.7M | €18.4M | €11.2M |
| Net profit margin | 9.12% | 8.00% | 6.31% | 5.59% |
| Basic EPSper basic share | €0.84 | €0.61 | €0.24 | €0.37 |
| Diluted EPSper diluted share | €0.84 | €0.61 | €0.24 | €0.37 |